Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (521-530 of 683) with videos related to

Pageof 69
Sort By:
BMC Infectious Diseases|April 19, 2015
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsEric J Bow, David J Vanness, Monica Slavin, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|February 2, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood|January 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.
Bone Marrow Transplantation|November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Canadian Medical Association Journal|August 9, 1975
Ampicillin-resistant strains of Hemophilus influenzaeR P Larke, L Chicoine, P Déry, et al.
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
Pageof 69

Showing results (521-530 of 683) with videos related to

Sort By:
Pageof 69
BMC Infectious Diseases|April 19, 2015
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsEric J Bow, David J Vanness, Monica Slavin, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
Blood|February 2, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Blood|January 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.
Bone Marrow Transplantation|November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Canadian Medical Association Journal|August 9, 1975
Ampicillin-resistant strains of Hemophilus influenzaeR P Larke, L Chicoine, P Déry, et al.
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
Pageof 69